Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Psychometric validation of the Dutch translation of the quality of life in reflux and dyspepsia (QOLRAD) questionnaire in patients with gastroesophageal reflux disease.

Engels LG, Klinkenberg-Knol EC, Carlsson J, Halling K.

Health Qual Life Outcomes. 2010 Aug 17;8:85. doi: 10.1186/1477-7525-8-85.

2.

Long-term results of external upper esophageal sphincter myotomy for oropharyngeal Dysphagia.

Kos MP, David EF, Klinkenberg-Knol EC, Mahieu HF.

Dysphagia. 2010 Sep;25(3):169-76. doi: 10.1007/s00455-009-9236-x. Epub 2009 Sep 17.

3.

A candidate gene approach of immune mediators effecting the susceptibility to and severity of upper gastrointestinal tract diseases in relation to Helicobacter pylori and Epstein-Barr virus infections.

Ouburg S, Bart A Crusius J, Klinkenberg-Knol EC, Mulder CJ, Salvador Peña A, Morré SA.

Eur J Gastroenterol Hepatol. 2005 Nov;17(11):1213-24. Review.

PMID:
16215434
4.

Long-term acid suppression by omeprazole in gastro-oesophageal reflux disease patients does not lead to anti-gastric autoantibody production.

Bergman MP, Klinkenberg-Knol EC, Faller G, Aar A, Lakhai W, Vandenbroucke-Grauls CM, Kuipers EJ, Appelmelk BJ.

Aliment Pharmacol Ther. 2005 Apr 15;21(8):977-83.

5.

The true ligand of the NOD2 receptor is peptidoglycan instead of lipopolysaccharide: a schematic representation of ligand-receptor interactions and NF-kappa B activation.

Morré SA, Ouburg S, Klinkenberg-Knol EC, Mulder CJ, Peña AS.

Gastroenterology. 2004 Jan;126(1):371-3. No abstract available.

PMID:
14753217
6.

Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial.

Kuipers EJ, Nelis GF, Klinkenberg-Knol EC, Snel P, Goldfain D, Kolkman JJ, Festen HP, Dent J, Zeitoun P, Havu N, Lamm M, Walan A.

Gut. 2004 Jan;53(1):12-20.

7.

Orofacial granulomatosis in a patient with Crohn's disease.

van de Scheur MR, van der Waal RI, Völker-Dieben HJ, Klinkenberg-Knol EC, Starink TM, van der Waal I.

J Am Acad Dermatol. 2003 Nov;49(5):952-4.

PMID:
14576691
8.

Endoscopic treatment of benign esophageal tumors: case report of three patients.

van der Peet DL, Berends FJ, Klinkenberg-Knol EC, Cuesta MA.

Surg Endosc. 2001 Dec;15(12):1489.

PMID:
11965474
9.

Percutaneous endoscopic gastrostomy: complications and suggestions to avoid them.

Schurink CA, Tuynman H, Scholten P, Arjaans W, Klinkenberg-Knol EC, Meuwissen SG, Kuipers EJ.

Eur J Gastroenterol Hepatol. 2001 Jul;13(7):819-23.

PMID:
11474312
10.

[Laparoscopic myotomy in 14 patients with achalasia after unsuccessful pneumatic dilatations: effective and safe].

van der Peet DL, Klinkenberg-Knol EC, Ong GL, Bonjer HJ, Cuesta MA.

Ned Tijdschr Geneeskd. 2001 Jun 23;145(25):1205-8. Dutch.

PMID:
11447877
11.

The prevalence of constipation in institutionalized people with intellectual disability.

Böhmer CJ, Taminiau JA, Klinkenberg-Knol EC, Meuwissen SG.

J Intellect Disabil Res. 2001 Jun;45(Pt 3):212-8.

PMID:
11422645
12.

Epiphrenic diverticula: minimal invasive approach and repair in five patients.

van der Peet DL, Klinkenberg-Knol EC, Berends FJ, Cuesta MA.

Dis Esophagus. 2001;14(1):60-2.

PMID:
11422309
13.

Effect of elimination of acid reflux on epithelial cell proliferative activity of Barrett esophagus.

Peters FT, Ganesh S, Kuipers EJ, Sluiter WJ, Karrenbeld A, de Jager-Krikken A, Klinkenberg-Knol EC, Lamers CB, Kleibeuker JH.

Scand J Gastroenterol. 2000 Dec;35(12):1238-44.

PMID:
11199360
14.

Gastroesophageal reflux disease in intellectually disabled individuals: how often, how serious, how manageable?

Böhmer CJ, Klinkenberg-Knol EC, Niezen-de Boer MC, Meuwissen SG.

Am J Gastroenterol. 2000 Aug;95(8):1868-72. Review.

PMID:
10950028
15.

Severe gastrointestinal symptoms due to lead poisoning from Indian traditional medicine.

van Vonderen MG, Klinkenberg-Knol EC, Craanen ME, Touw DJ, Meuwissen SG, De Smet PA.

Am J Gastroenterol. 2000 Jun;95(6):1591-2. No abstract available.

PMID:
10894609
16.

[Gastroesophageal reflux disease in mentally retarded persons: prevalence, diagnosis and treatment].

Böhmer CJ, Klinkenberg-Knol EC, Niezen-de Boer MC, Meuwissen SG.

Ned Tijdschr Geneeskd. 2000 Jun 10;144(24):1156-61. Review. Dutch.

PMID:
10876694
17.

Parietal cell protrusions and fundic gland cysts during omeprazole maintenance treatment.

Cats A, Schenk BE, Bloemena E, Roosedaal R, Lindeman J, Biemond I, Klinkenberg-Knol EC, Meuwissen SG, Kuipers EJ.

Hum Pathol. 2000 Jun;31(6):684-90.

PMID:
10872661
18.

Helicobacter pylori, proton pump inhibitors and gastroesophageal reflux disease.

Kuipers EJ, Klinkenberg-Knol EC, Meuwissen SG.

Yale J Biol Med. 1999 Mar-Jun;72(2-3):211-8. Review.

19.

Effect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy.

Schenk BE, Kuipers EJ, Nelis GF, Bloemena E, Thijs JC, Snel P, Luckers AE, Klinkenberg-Knol EC, Festen HP, Viergever PP, Lindeman J, Meuwissen SG.

Gut. 2000 May;46(5):615-21.

20.

Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa.

Klinkenberg-Knol EC, Nelis F, Dent J, Snel P, Mitchell B, Prichard P, Lloyd D, Havu N, Frame MH, Romàn J, Walan A; Long-Term Study Group.

Gastroenterology. 2000 Apr;118(4):661-9.

PMID:
10734017
21.

Laparoscopic treatment of large hiatal hernias.

Cuesta MA, van der Peet DL, Klinkenberg-Knol EC.

Semin Laparosc Surg. 1999 Dec;6(4):213-23.

PMID:
10684553
22.

Laparoscopic or conventional Nissen fundoplication for gastro-oesophageal reflux disease: randomised clinical trial. The Netherlands Antireflux Surgery Study Group.

Bais JE, Bartelsman JF, Bonjer HJ, Cuesta MA, Go PM, Klinkenberg-Knol EC, van Lanschot JJ, Nadorp JH, Smout AJ, van der Graaf Y, Gooszen HG.

Lancet. 2000 Jan 15;355(9199):170-4.

PMID:
10675115
23.

Listeria sepsis as a complication of endoscopy.

Witlox MA, Klinkenberg-Knol EC, Meuwissen SG.

Gastrointest Endosc. 2000 Feb;51(2):235-6. No abstract available.

PMID:
10650280
24.

Omeprazole and accelerated onset of atrophic gastritis.

Kuipers EJ, Klinkenberg-Knol EC, Meuwissen SG.

Gastroenterology. 2000 Jan;118(1):239-42. No abstract available.

PMID:
10644182
25.

Laparoscopic treatment of large paraesophageal hernias: both excision of the sac and gastropexy are imperative for adequate surgical treatment.

van der Peet DL, Klinkenberg-Knol EC, Alonso Poza A, Sietses C, Eijsbouts QA, Cuesta MA.

Surg Endosc. 2000 Nov;14(11):1015-8.

PMID:
11116408
26.

Helicobacter pylori and omeprazole therapy in GERD.

Kuipers EJ, Schenk BE, Klinkenberg-Knol EC, Meuwissen SG.

Am J Gastroenterol. 1999 Nov;94(11):3378-9. No abstract available.

PMID:
10566757
27.

Atrophic gastritis during long-term omeprazole therapy affects serum vitamin B12 levels.

Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, Bloemena EC, Sandell M, Nelis GF, Snel P, Festen HP, Meuwissen SG.

Aliment Pharmacol Ther. 1999 Oct;13(10):1343-6.

28.

Endoscopic regression of Barrett's oesophagus during omeprazole treatment; a randomised double blind study.

Peters FT, Ganesh S, Kuipers EJ, Sluiter WJ, Klinkenberg-Knol EC, Lamers CB, Kleibeuker JH.

Gut. 1999 Oct;45(4):489-94. Erratum in: Gut 2000 Jul;47(1):154-5.

29.

The influence of Helicobacter pylori on oesophageal acid exposure in GERD during acid suppressive therapy.

Peters FT, Kuipers EJ, Ganesh S, Sluiter WJ, Klinkenberg-Knol EC, Lamers CB, Kleibeuker JH.

Aliment Pharmacol Ther. 1999 Jul;13(7):921-6.

30.

Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease.

Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, Eskes SA, Meuwissen SG.

Am J Gastroenterol. 1999 Apr;94(4):884-7.

PMID:
10201451
31.

The prevalence of gastroesophageal reflux disease in institutionalized intellectually disabled individuals.

Böhmer CJ, Niezen-de Boer MC, Klinkenberg-Knol EC, Devillé WL, Nadorp JH, Meuwissen SG.

Am J Gastroenterol. 1999 Mar;94(3):804-10.

PMID:
10086670
32.

Helicobacter pylori, acid, and omeprazole revisited: bacterial eradication and rebound hypersecretion.

Kuipers EJ, Klinkenberg-Knol EC.

Gastroenterology. 1999 Feb;116(2):479-83. Review. No abstract available.

PMID:
9922329
33.

Omeprazole: therapy of choice in intellectually disabled children.

Böhmer CJ, Niezen-de Boer RC, Klinkenberg-Knol EC, Meuwissen SG.

Arch Pediatr Adolesc Med. 1998 Nov;152(11):1113-8.

PMID:
9811290
34.

[Good short-term and mid-term results after laparoscopic Nissen fundoplication for gastroesophageal reflux].

de Ruiter P, Cuesta MA, Bijnen AB, Klinkenberg-Knol EC, Lourens J, van der Peet D.

Ned Tijdschr Geneeskd. 1998 Jun 6;142(23):1316-20. Dutch.

PMID:
9752037
35.

Laparoscopic Nissen fundoplication for the treatment of gastroesophageal reflux disease (GERD). Surgery after extensive conservative treatment.

van der Peet DL, Klinkenberg-Knol EC, Eijsbouts QA, van den Berg M, de Brauw LM, Cuesta MA.

Surg Endosc. 1998 Sep;12(9):1159-63.

PMID:
9716773
36.

Hypergastrinaemia during long-term omeprazole therapy: influences of vagal nerve function, gastric emptying and Helicobacter pylori infection.

Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, Bloemena E, Nelis GF, Festen HP, Jansen EH, Biemond I, Lamers CB, Meuwissen SG.

Aliment Pharmacol Ther. 1998 Jul;12(7):605-12.

37.

Epithelial cell proliferative activity of Barrett's esophagus: methodology and correlation with traditional cancer risk markers.

Peters FT, Ganesh S, Kuipers EJ, de Jager-Krikken A, Karrenbeld A, Harms G, Sluiter WJ, Koudstaal J, Klinkenberg-Knol EC, Lamers CB, Kleibeuker JH.

Dig Dis Sci. 1998 Jul;43(7):1501-6.

PMID:
9690386
38.

Dental erosions and gastro-oesophageal reflux disease in institutionalized intellectually disabled individuals.

Böhmer CJ, Klinkenberg-Knol EC, Niezen-de Boer MC, Meuwissen PR, Meuwissen SG.

Oral Dis. 1997 Dec;3(4):272-5.

PMID:
9643224
39.

[Reflux esophagitis; is the preventive eradication of Helicobacter pylori needed in patients on omeprazole?].

Kuipers EJ, Klinkenberg-Knol EC, Festen HP, Meuwissen SG.

Ned Tijdschr Geneeskd. 1998 Apr 18;142(16):883-5. Dutch.

PMID:
9623181
40.

Otolaryngologic manifestations of gastro-oesophageal reflux disease.

Klinkenberg-Knol EC.

Scand J Gastroenterol Suppl. 1998;225:24-8. Review.

PMID:
9515748
41.

Gastro-oesophageal reflux disease in institutionalised intellectually disabled individuals.

Böhmer CJ, Niezen-de Boer MC, Klinkenberg-Knol EC, Nadorp JH, Meuwissen SG.

Neth J Med. 1997 Oct;51(4):134-9.

PMID:
9446923
42.

Lansoprazole, H. pylori, and atrophic gastritis.

Kuipers EJ, Klinkenberg-Knol EC, Festen HP, Meuwissen SG.

Gastroenterology. 1997 Dec;113(6):2018-9. No abstract available.

PMID:
9394746
43.

Omeprazole as a diagnostic tool in gastroesophageal reflux disease.

Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, Festen HP, Jansen EH, Tuynman HA, Schrijver M, Dieleman LA, Meuwissen SG.

Am J Gastroenterol. 1997 Nov;92(11):1997-2000.

PMID:
9362179
44.

Gastroesophageal reflux disease in intellectually disabled individuals: leads for diagnosis and the effect of omeprazole therapy.

Bohmer CJ, Niezen-de Boer MC, Klinkenberg-Knol EC, Tuynman HA, Voskuil JH, Devillé WL, Meuwissen SG.

Am J Gastroenterol. 1997 Sep;92(9):1475-9.

PMID:
9317066
45.

The age-related incidences of oesophageal carcinoma in intellectually disabled individuals in institutes in The Netherlands.

Böhmer CJ, Klinkenberg-Knol EC, Niezen-de Boer RC, Meuwissen SG.

Eur J Gastroenterol Hepatol. 1997 Jun;9(6):589-92.

PMID:
9222731
46.

The prevalence of Helicobacter pylori infection among inhabitants and healthy employees of institutes for the intellectually disabled.

Böhmer CJ, Klinkenberg-Knol EC, Kuipers EJ, Niezen-de Boer MC, Schreuder H, Schuckink-Kool F, Meuwissen SG.

Am J Gastroenterol. 1997 Jun;92(6):1000-4.

PMID:
9177519
47.

The prevalence of gastro-oesophageal reflux disease based on non-specific symptoms in institutionalized, intellectually disabled individuals.

Böhmer CJ, Klinkenberg-Knol EC, Niezen-de Boer RC, Meuwissen SG.

Eur J Gastroenterol Hepatol. 1997 Feb;9(2):187-90.

PMID:
9058632
48.

Role of Helicobacter pylori in the pathogenesis of atrophic gastritis.

Kuipers EJ, Klinkenberg-Knol EC, Vandenbroucke-Grauls CM, Appelmelk BJ, Schenk BE, Meuwissen SG.

Scand J Gastroenterol Suppl. 1997;223:28-34. Review.

PMID:
9200303
49.

Effect of short- and long-term treatment with omeprazole on the absorption and serum levels of cobalamin.

Schenk BE, Festen HP, Kuipers EJ, Klinkenberg-Knol EC, Meuwissen SG.

Aliment Pharmacol Ther. 1996 Aug;10(4):541-5.

PMID:
8853757
50.

Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication.

Kuipers EJ, Lundell L, Klinkenberg-Knol EC, Havu N, Festen HP, Liedman B, Lamers CB, Jansen JB, Dalenback J, Snel P, Nelis GF, Meuwissen SG.

N Engl J Med. 1996 Apr 18;334(16):1018-22.

Supplemental Content

Loading ...
Support Center